| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 375 | 6.402 | 29.664 | 58.815 |
| Total Income - EUR | - | - | - | - | - | - | 375 | 6.402 | 29.664 | 58.815 |
| Total Expenses - EUR | - | - | - | - | - | - | 332 | 1.256 | 16.598 | 24.682 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 43 | 5.146 | 13.066 | 34.133 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 32 | 4.975 | 10.912 | 32.492 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Rbc Oncology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 2.477 | 3.453 | 5.269 |
| Current Assets | - | - | - | - | - | - | 402 | 2.831 | 10.211 | 28.938 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 375 | 365 | 3.496 | 23.231 |
| Cash | - | - | - | - | - | - | 27 | 2.466 | 6.715 | 5.708 |
| Shareholders Funds | - | - | - | - | - | - | 52 | 5.027 | 10.936 | 32.516 |
| Social Capital | - | - | - | - | - | - | 20 | 20 | 20 | 20 |
| Debts | - | - | - | - | - | - | 350 | 284 | 2.737 | 1.702 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rbc Oncology S.r.l.